Literature DB >> 20031681

Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.

Adnan K Chhatriwalla1, Deepak L Bhatt.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 20031681     DOI： 10.1161/CIRCINTERVENTIONS.108.811380

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  3 in total

1.  Ultrasound-guided peripheral nerve blocks for a patient receiving four kinds of anticoagulant and antiplatelet drugs: a case report.

Authors:  Hideki Taninishi; Kiyoshi Morita
Journal:  J Anesth       Date:  2011-02-02       Impact factor: 2.078

2.  The nanomedicine revolution: part 2: current and future clinical applications.

Authors:  C Lee Ventola
Journal:  P T       Date:  2012-10

3.  Relationships between PON1 Q192R polymorphism and clinical outcome of antiplatelet treatment after percutaneous coronary intervention: a meta-analysis.

Authors:  Ping Li; Shu-Hong Bu; Xiao-Tong Lu; Li-Xia Li; A-Jing Xu; Yue-Nian Tang; Jian Zhang
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.